After the success of the European program REBORNE (FP7) focused on safety and efficacy of the Biomatlante matrix combined with autologous bone marrow expanded mesenchymal stem cells (MSC), MBCP+™, made from our well-known MBCP Technology, was confirmed as the adapted matrix for tissue engineering and chosen for 2 new European research programs (H2020): MAXIBONE and ORTHOUNION.
Introduction: Bone is the most transplanted tissue in human with about 1 million procedures annually in Europe. Autologous bone grafting is the gold standard in bone regeneration but it requires a second surgery, is limited in quantity and often associated with painful complications. Synthetic calcium phosphate biomaterial in association with mesenchymal stem cells may be a potent alternative to autologous bone grafting.
Emmanuel Macron, minister of Economy, met May 18, 2015 in Nantes, with the actors mobilized for the reindustrialization project “the Industry of the Future”, new array of industrial strategy. On its way to play a mainly role in the phase II of New Industrial France (NFI), this project aims to modernize the industrial tool and transform its business model by digital.
Prochains Evènements
-
(May 08, 2024 ) -
(October 02, 2024 )
Evènements passés
-
(January 29, 2024 ) -
(October 24, 2023 ) -
(October 04, 2023 ) -
(March 14, 2023 ) -
(March 08, 2023 ) -
(October 25, 2022 ) -
(October 19, 2022 ) -
(October 12, 2022 ) -
(October 06, 2021 ) -
(September 29, 2021 ) -
(September 01, 2021 ) -
(May 11, 2021 )